The mutual exclusivity of BRAF and KRAS mutations in AAHs and the disparate pattern of mutations in the paired lung adenocarcinomas suggest divergent pathways in the pathogenesis of preneoplastic lesions of lung adenocarcinomas [30]. The gene discussed is KRAS; the disease is lung adenocarcinoma.